| Trial ID: | L0563 |
| Source ID: | NCT02973295
|
| Associated Drug: |
Silymarin
|
| Title: |
Silymarin?? - Efficacy in Treatment of Non-alcoholic Fatty Liver Disease (NAFLD) Controlled by Laboratory and and Elastographic Parameters
|
| Acronym: |
SINF
|
| Status: |
Not recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Non-Alcoholic Fatty Liver Disease
|
| Interventions: |
Drug: Silymarin;Other: Placebo Oral Capsule
|
| Outcome Measures: |
Change (Reduction) of parameters of liver steatosis defined by CAP (Controlled Attenuation Parameter) and liver fibrosis defined by LSM (liver stiffness measurements) during the 6 months periodChange in liver enzymes in period of 6 months;Change in insulin resistance in period of 6 months;Change in lipidogram in period of 6 months
|
| Sponsor/Collaborators: |
University Hospital Rijeka
|
| Gender: |
All
|
| Age: |
18 Years70 Years
|
| Phases: |
Phase 4
|
| Enrollment: |
0
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Investigator, Outcomes Assessor).
|
| Start Date: |
04/11/2016
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
12 December 2020
|
| Locations: |
Croatia
|
| URL: |
https://clinicaltrials.gov/show/NCT02973295
|
